Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.46 |
| ▸ | GNPAT | O15228 | 1/20 | 0.46 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30886538 | 1.00 | MME (0.46) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL29591002 | 1.00 | MME (0.46) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL30881174 | 1.00 | MME (0.46) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL29630398 | 0.98 | MME (0.47) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL29503906 | 0.98 | MME (0.47) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL30193323 | 0.98 | MME (0.47) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL30099579 | 0.97 | MME (0.50) | MMEGNPATTGFBR1ENPEPPDCD1LG2 | |
| SCHEMBL29591607 | 0.97 | MME (0.50) | MMEGNPATTGFBR1ENPEPPDCD1LG2 | |
| SCHEMBL31064879 | 0.97 | GNPAT (0.48) | MMEGNPATTGFBR1ENPEPCA2 | |
| SCHEMBL29679876 | 0.95 | MME (0.51) | MMEGNPATTGFBR1ENPEPPDCD1LG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117695408-A | Drug delivery nano-carrier and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2024-03-15 | — | — | CN | claimed |
| EP-4673179-A1 | BONE-DIRECTED THERAPEUTICS FOR THE TREATMENT OF CANCER | William Marsh Rice University (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024254472-A1 | OSTEOCLAST-DERIVED MICROVESICLES AND METHODS OF PROMOTING BONE REGENERATION | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2024-12-12 | — | — | WO | disclosed |
| CN-119055683-A | Preparation method and application of osteoblast targeting engineering cow milk small extracellular vesicles | 大连医科大学 | 2024-12-03 | — | — | CN | disclosed |
| WO-2024182454-A1 | BONE-DIRECTED THERAPEUTICS FOR THE TREATMENT OF CANCER | WILLIAM MARSH RICE UNIVERSITY (US) | 2024-09-06 | — | — | WO | disclosed |
| CN-117695408-A | Drug delivery nano-carrier and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2024-03-15 | — | — | CN | disclosed |